Quest Diagnostics Incorporated (DGX) Q1 2022 Earnings Results

Quest Diagnostics Beats on EPS, Stock Up 2.3%

Quest Diagnostics reported a strong EPS performance, exceeding expectations by 10.77%. The stock reacted positively, rising by 2.3%. Investors may view this as a sign of the company's resilience and ability to manage costs effectively, despite the lack of revenue details and future guidance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.22	N/A	+10.77%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to quality services. However, no specific guidance was provided for future quarters.

We are pleased with our EPS performance this quarter.

Our focus remains on delivering quality diagnostic services.

Quest Diagnostics Beats on EPS, Stock Up 2.3%

Key numbers

Management commentary

Quest Diagnostics Incorporated

More earnings this week

Quest Diagnostics Beats on EPS, Stock Up 2.3%

Key numbers

Management commentary